Clinical prediction models on OMOP: how to build models that work beyond one hospital

The problem with most prediction models

The Book of OHDSI is direct about it: many published patient-level prediction efforts don't follow model development guidelines, fail to perform extensive external validation, or provide too few details for others to reproduce and validate them¹. It points to the TRIPOD reporting guideline as a standard for transparent reporting¹⁴.

The underlying issue is that a model learns the habits of the data it was trained on: coding practices, patient mix, documentation patterns. Those don't travel.

Define the problem precisely

OHDSI frames every prediction problem in the same form: among a target cohort, who will go on to have an outcome within a time-at-risk? Prediction happens at a defined moment, and only information from the observation window before that moment may be used¹.

The same template covers disease onset, treatment response, safety and adherence. The book's examples include predicting ischaemic stroke among newly diagnosed atrial fibrillation patients, and gastrointestinal bleeding among new users of warfarin¹. Because target and outcome are standard cohort definitions, another site can rebuild exactly the same problem on its own data.

Measure the right things

Discrimination, usually summarised by the area under the ROC curve, measures whether the model ranks patients who will have the outcome above those who won't. The book notes that for rare outcomes even a model with a high AUC may not be practical, because many false positives can accompany each true one¹.

Calibration measures whether predicted risks match reality: of a hundred patients given a 10% risk, about ten should have the outcome¹. In the book's worked example, a model was well calibrated overall but poorly calibrated for younger patients¹. Overall metrics hide that kind of problem, which is why subgroup checks matter for both safety and fairness.

Validate externally, always

The book distinguishes internal validation, testing on held-out data from the same database, from external validation, developing in one database and evaluating in another. It recommends always performing external validation on as many new datasets as feasible, because different databases represent different populations, health systems and data capture¹.

This is where a common data model pays off. A model built on OMOP can be shared as a package and evaluated at other OMOP sites without moving patient data, which is the federated approach described in federated health analytics. The PatientLevelPrediction R package implements this end to end, from data extraction with standard covariates to training and validation²³.

How I'd run a clinical prediction project

1. Write the prediction question in the standard form and agree it with clinicians before touching data.
2. Build cohorts on OMOP, checked with data quality tools, so the design is portable.
3. Start with simple models. Regularised logistic regression is often competitive and easier to explain.
4. Report discrimination and calibration, overall and by key subgroups, following TRIPOD.
5. Validate on at least one external dataset before any clinical use.
6. Plan deployment and monitoring: how the score reaches clinicians, how drift is detected, and how changes are controlled. The transparency practices in HTI-1 to HTI-5 and FDA PCCPs apply.

How I can help

I design OMOP-based platforms and clinical AI pipelines that make prediction models reproducible, externally validated and safe to deploy. See healthcare data architecture, or analyse your challenge and bring the result to a call.